David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
CALL
Capital One
COF
$133B
| $3.98M | 0.01% |
48,700
+27,900
| +134% | +$2.27M |
|
|
1652
PUT
Capital One
COF
$133B
| $3.98M | 0.01% |
48,700
+20,800
| +75% | +$1.69M |
|
1653
FerroAtlántica
GSM
$761M
| $3.98M | 0.01% |
1,940,589
+349,438
| +22% | +$795K |
|
1654
TTM Technologies
TTMI
$12.8B
| $3.98M | 0.01% |
339,106
+135,952
| +67% | +$1.56M |
|
1655
Chemed
CHE
$7.17B
| $3.98M | 0.01% |
12,421
-42,607
| -77% | -$13.1M |
|
1656
Warrior Met Coal
HCC
$5.56B
| $3.97M | 0.01% |
+130,614
| New | +$3.57M |
|
|
BRSS
1657
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $3.94M | 0.01% |
114,508
-7,558
| -6% | -$234K |
|
|
BFI
1658
DELISTED
BurgerFi International, Inc. Common Stock
BFI
| $3.94M | 0.01% |
388,500
| – | – |
|
|
SG
1659
DELISTED
Sirius International Insurance Group, Ltd. Common Share
SG
| $3.94M | 0.01% |
304,427
| – | – |
|
1660
PUT
NOV
NOV
$7.21B
| $3.94M | 0.01% |
147,900
+114,900
| +348% | +$3.26M |
|
1661
PUT
Vipshop
VIPS
$6.7B
| $3.94M | 0.01% |
490,000
-862,000
| -64% | -$6.11M |
|
1662
Funko
FNKO
$357M
| $3.93M | 0.01% |
+180,937
| New | +$3.32M |
|
|
SAIL
1663
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $3.92M | 0.01% |
+136,695
| New | +$3.89M |
|
|
IPHS
1664
DELISTED
Innophos Holdings, Inc.
IPHS
| $3.92M | 0.01% |
130,233
-63,288
| -33% | -$1.9M |
|
1665
VanEck Gold Miners ETF
GDX
$31.9B
| $3.92M | 0.01% |
+175,000
| New | +$3.85M |
|
1666
Banner Corp
BANR
$2.39B
| $3.92M | 0.01% |
72,428
-16,601
| -19% | -$944K |
|
1667
CALL
Lear
LEA
$8.28B
| $3.92M | 0.01% |
28,900
+15,500
| +116% | +$2.27M |
|
1668
CNX Resources
CNX
$5.33B
| $3.92M | 0.01% |
363,726
-659,063
| -64% | -$7.44M |
|
|
OMN
1669
DELISTED
OMNOVA Solutions Inc.
OMN
| $3.91M | 0.01% |
556,935
+117,625
| +27% | +$940K |
|
1670
Tractor Supply
TSCO
$18.2B
| $3.9M | 0.01% |
199,745
-6,094,135
| -97% | -$111M |
|
1671
Azenta
AZTA
$1.47B
| $3.9M | 0.01% |
132,909
+13,286
| +11% | +$400K |
|
1672
CALL
WIX.com
WIX
$3.44B
| $3.89M | 0.01% |
32,200
-5,600
| -15% | -$608K |
|
1673
Vera Bradley
VRA
$95.3M
| $3.88M | 0.01% |
293,126
+146,250
| +100% | +$1.49M |
|
|
MRSH
1674
Marsh
MRSH
$92.2B
| $3.88M | 0.01% |
41,327
-74,800
| -64% | -$6.62M |
|
|
1675
CALL
AbbVie
ABBV
$465B
| $3.87M | 0.01% |
48,000
-288,400
| -86% | -$23.6M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.